Aardvark Therapeutics Inc. Common Stock (AARD) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Aardvark Therapeutics Inc...

    NASDAQ: AARD · Real-Time Price · USD
    17.00
    0.92 (5.72%)
    At close: Oct 06, 2025, 1:39 PM

    Aardvark Therapeutics Common Stock Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    PE Ratio
    		 -8.97 -25.63 -10.27
    PEG Ratio
    		 -0.05 0.43 n/a
    PS Ratio
    		 n/a n/a n/a
    PB Ratio
    		 -3.38 -5.31 -4.99
    P/FCF Ratio
    		 -10.15 -31.72 -13.21
    P/OCF Ratio
    		 -10.21 -31.72 -13.21
    OCF/S Ratio
    		 n/a n/a n/a
    Debt / Equity Ratio
    		 -0.01 -0.00 -0.01
    Quick Ratio
    		 15.05 7.50 27.72
    Current Ratio
    		 15.05 7.50 27.72
    Asset Turnover
    		 n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a
    Return on Equity
    		 0.38 0.21 0.49
    Return on Assets
    		 -0.27 -0.68 -0.81
    Return on Invested Capital
    		 -0.31 -0.79 -0.69
    Dividend Yield
    		 n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a

    Add to Watchlist